Table of Contents

1 Study Coverage

• 1.1 Glycobiology Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Glycobiology Market Size Growth Rate by Product
  • 1.4.2 Reagents
  • 1.4.3 Instruments
  • 1.4.4 Kits
  • 1.4.5 Enzymes
• 1.5 Market by End User
  • 1.5.1 Global Glycobiology Market Size Growth Rate by End User
  • 1.5.2 Drug Discovery and Development
  • 1.5.3 Immunology
  • 1.5.4 Diagnostics
  • 1.5.5 Oncology
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Glycobiology Market Size
  • 2.1.1 Global Glycobiology Revenue 2014-2025
  • 2.1.2 Global Glycobiology Sales 2014-2025
• 2.2 Glycobiology Growth Rate by Regions
  • 2.2.1 Global Glycobiology Sales by Regions
  • 2.2.2 Global Glycobiology Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Glycobiology Sales by Manufacturers
  • 3.1.1 Glycobiology Sales by Manufacturers
  • 3.1.2 Glycobiology Sales Market Share by Manufacturers
  • 3.1.3 Global Glycobiology Market Concentration Ratio (CR5 and HHI)
• 3.2 Glycobiology Revenue by Manufacturers
  • 3.2.1 Glycobiology Revenue by Manufacturers (2014-2019)
  • 3.2.2 Glycobiology Revenue Share by Manufacturers (2014-2019)
• 3.3 Glycobiology Price by Manufacturers
• 3.4 Glycobiology Manufacturing Base Distribution, Product Types
  • 3.4.1 Glycobiology Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Glycobiology Product Type
  • 3.4.3 Date of International Manufacturers Enter into Glycobiology Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Glycobiology Sales by Product
• 4.2 Global Glycobiology Revenue by Product
• 4.3 Glycobiology Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Glycobiology Breakdown Data by End User

6 North America

• 6.1 North America Glycobiology by Countries
  • 6.1.1 North America Glycobiology Sales by Countries
  • 6.1.2 North America Glycobiology Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Glycobiology by Product
• 6.3 North America Glycobiology by End User

7 Europe

• 7.1 Europe Glycobiology by Countries
  • 7.1.1 Europe Glycobiology Sales by Countries
  • 7.1.2 Europe Glycobiology Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Glycobiology by Product
• 7.3 Europe Glycobiology by End User

8 Asia Pacific

• 8.1 Asia Pacific Glycobiology by Countries
  • 8.1.1 Asia Pacific Glycobiology Sales by Countries
  • 8.1.2 Asia Pacific Glycobiology Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Glycobiology by Product
• 8.3 Asia Pacific Glycobiology by End User

9 Central & South America

• 9.1 Central & South America Glycobiology by Countries
  • 9.1.1 Central & South America Glycobiology Sales by Countries
  • 9.1.2 Central & South America Glycobiology Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Glycobiology by Product
• 9.3 Central & South America Glycobiology by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Glycobiology by Countries
  • 10.1.1 Middle East and Africa Glycobiology Sales by Countries
  • 10.1.2 Middle East and Africa Glycobiology Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Glycobiology by Product
• 10.3 Middle East and Africa Glycobiology by End User

11 Company Profiles

• 11.1 Agilent Technologies
  • 11.1.1 Agilent Technologies Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Agilent Technologies Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Agilent Technologies Glycobiology Products Offered
  • 11.1.5 Agilent Technologies Recent Development
• 11.2 Bruker Corp
  • 11.2.1 Bruker Corp Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bruker Corp Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bruker Corp Glycobiology Products Offered
  • 11.2.5 Bruker Corp Recent Development
• 11.3 Waters Corp
  • 11.3.1 Waters Corp Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Waters Corp Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Waters Corp Glycobiology Products Offered
  • 11.3.5 Waters Corp Recent Development
• 11.4 Thermo Fisher Scientific
  • 11.4.1 Thermo Fisher Scientific Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Thermo Fisher Scientific Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Thermo Fisher Scientific Glycobiology Products Offered
  • 11.4.5 Thermo Fisher Scientific Recent Development
• 11.5 Takara Bio
  • 11.5.1 Takara Bio Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Takara Bio Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Takara Bio Glycobiology Products Offered
  • 11.5.5 Takara Bio Recent Development
• 11.6 Merck
  • 11.6.1 Merck Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Merck Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Merck Glycobiology Products Offered
  • 11.6.5 Merck Recent Development
• 11.7 Shimadzu Corp
  • 11.7.1 Shimadzu Corp Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Shimadzu Corp Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Shimadzu Corp Glycobiology Products Offered
  • 11.7.5 Shimadzu Corp Recent Development
• 11.8 Prozyme
  • 11.8.1 Prozyme Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Prozyme Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Prozyme Glycobiology Products Offered
  • 11.8.5 Prozyme Recent Development
• 11.9 New England Biolabs
  • 11.9.1 New England Biolabs Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 New England Biolabs Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 New England Biolabs Glycobiology Products Offered
  • 11.9.5 New England Biolabs Recent Development
• 11.10 Danaher Corp
  • 11.10.1 Danaher Corp Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Danaher Corp Glycobiology Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Danaher Corp Glycobiology Products Offered
  • 11.10.5 Danaher Corp Recent Development

12 Future Forecast

• 12.1 Glycobiology Market Forecast by Regions
  • 12.1.1 Global Glycobiology Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Glycobiology Revenue Forecast by Regions 2019-2025
• 12.2 Glycobiology Market Forecast by Product
  • 12.2.1 Global Glycobiology Sales Forecast by Product 2019-2025
  • 12.2.2 Global Glycobiology Revenue Forecast by Product 2019-2025
• 12.3 Glycobiology Market Forecast by End User
• 12.4 North America Glycobiology Forecast
• 12.5 Europe Glycobiology Forecast
• 12.6 Asia Pacific Glycobiology Forecast
• 12.7 Central & South America Glycobiology Forecast
• 12.8 Middle East and Africa Glycobiology Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Glycobiology Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Glycobiology is a monthly peer-reviewed scientific journal covering all aspects of the field of glycobiology and the official journal of the Society for Glycobiology.
It is very helpful in biotechnological research and biomedicine.
Carbohydrates control almost all the aspects of cellular processing that involves cell-cell interactions, adhesion mechanisms, signalling for growth factors, blood clotting, regulating hormonal activity, and it also directs embryonic development.
Glycobiology market is in the emerging state mainly due to the increase in expenditure by different pharmaceutical companies on R&D.
The global Glycobiology market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glycobiology market based on company, product type, end user and key regions.

This report studies the global market size of Glycobiology in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glycobiology in these regions.
This research report categorizes the global Glycobiology market by top players/brands, region, type and end user. This report also studies the global Glycobiology market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Agilent Technologies
Bruker Corp
Waters Corp
Thermo Fisher Scientific
Takara Bio
Merck
Shimadzu Corp
Prozyme
New England Biolabs
Danaher Corp

Market size by Product
Reagents
Instruments
Kits
Enzymes
Market size by End User
Drug Discovery and Development
Immunology
Diagnostics
Oncology
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Glycobiology market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Glycobiology market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Glycobiology companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Glycobiology submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Glycobiology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glycobiology market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.